Are you a process development scientist or CMC leader navigating scale-up, tech transfer, GMP readiness, or process validation across upstream and downstream development?
Are you selecting a CDMO partner and want to avoid costly surprises in tech transfer and manufacturing execution?
Are you a biotech founder preparing for an IND or Series A and need a CMC strategy that holds up under investor and regulatory scrutiny, without costly trial and error?
There is a more direct path. Practical, execution-focused guidance on the decisions that actually move programs forward, from lab to clinic to commercial scale.
Learn how leading CMC scientists and manufacturing executives do it.
